Gene · 407014
Papers3,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Roles of Exosomes in Metastasis of Sarcoma: From Biomarkers to Therapeutic Targets. | Biomolecules | 2023 | 36979391 | PubTator, text mining | PubMed |
| Rolling circle extension-assisted loop-mediated isothermal amplification (Rol-LAMP) method for locus-specific and visible detection of RNA N6-methyladenosine. | Nucleic Acids Res | 2023 | 36971119 | PubTator, text mining | PubMed |
| Exosomes: The role in mammalian reproductive regulation and pregnancy-related diseases. | Front Physiol | 2023 | 36969587 | PubTator, text mining | PubMed |
| Ezrin expression in female reproductive tissues: A review of regulation and pathophysiological implications. | Front Cell Dev Biol | 2023 | 36968198 | PubTator, text mining | PubMed |
| HDAC2 as a target for developing anti-cancer drugs. | Comput Struct Biotechnol J | 2023 | 36968022 | PubTator, text mining | PubMed |
| The function and mechanisms of action of circular RNAs in Urologic Cancer. | Mol Cancer | 2023 | 36966306 | PubTator, text mining | PubMed |
| Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion. | Noncoding RNA | 2023 | 36960962 | PubTator, text mining | PubMed |
| Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation. | Cancer Cell Int | 2023 | 36959615 | PubTator, text mining | PubMed |
| MicroRNA Profiling of Self-Renewing Human Neural Stem Cells Reveals Novel Sets of Differentially Expressed microRNAs During Neural Differentiation In Vitro. | Stem Cell Rev Rep | 2023 | 36918496 | PubTator, text mining | PubMed |
| Emerging role of miRNAs, lncRNAs, and circRNAs in pregnancy-associated diseases. | Chin Med J (Engl) | 2023 | 36914956 | PubTator, text mining | PubMed |
| Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data. | Front Immunol | 2023 | 36911742 | PubTator, text mining | PubMed |
| miRNA-205: a future therapeutic molecule for liver diseases. | Future Drug Discov | 2023 | 36908931 | PubTator, text mining | PubMed |
| Endothelial plasticity across PTEN and Hippo pathways: A complex hormetic rheostat modulated by extracellular vesicles. | Transl Oncol | 2023 | 36905871 | PubTator, text mining | PubMed |
| The Role of Natural and Semi-Synthetic Compounds in Ovarian Cancer: Updates on Mechanisms of Action, Current Trends and Perspectives. | Molecules | 2023 | 36903316 | PubTator, text mining | PubMed |
| Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior. | Int J Mol Sci | 2023 | 36902096 | PubTator, text mining | PubMed |
| Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis. | Int J Mol Sci | 2023 | 36901807 | PubTator, text mining | PubMed |
| The Threat Posed by Environmental Contaminants on Neurodevelopment: What Can We Learn from Neural Stem Cells? | Int J Mol Sci | 2023 | 36901772 | PubTator, text mining | PubMed |
| Stem cell-derived extracellular vesicles: A novel and potential remedy for primary ovarian insufficiency. | Front Cell Dev Biol | 2023 | 36875770 | PubTator, text mining | PubMed |
| Epigenetic reprogramming in pancreatic premalignancy and clinical implications. | Front Oncol | 2023 | 36874143 | PubTator, text mining | PubMed |
| Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma. | Commun Med (Lond) | 2023 | 36869161 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407014/papers?page=16